Quarterly results
consolidated · as filed with NSE · Q1 FY27 back to Q4 FY24
| ₹ crore | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,063 | 1,003 | 942 | 804 | 761 | 756 | 720 | 687 | 677 | 673 |
| Other income | 29 | 10.8 | 19.4 | 19.7 | 22.1 | 25.6 | 37.7 | 21.4 | 22.5 | 23.2 |
| Total expenses | 939 | 889 | 827 | 691 | 631 | 632 | 612 | 584 | 579 | 565 |
| EBITDA | 174 | 164 | 160 | 141 | 155 | 148 | 132 | 126 | 129 | 139 |
| EBITDA margin | 16.4% | 16.3% | 16.9% | 17.5% | 20.4% | 19.5% | 18.3% | 18.4% | 19.1% | 20.6% |
| Finance costs | 6.4 | 7.2 | 4.6 | 3.8 | 3.7 | 3.1 | 3.2 | 4 | 11.7 | 12.3 |
| Depreciation | 44.1 | 41.8 | 39.6 | 23.4 | 21.6 | 20.7 | 20 | 19.4 | 20.1 | 18.5 |
| Profit before tax | 153 | 105 | 135 | 133 | 152 | 149 | 146 | 124 | 120 | 134 |
| Tax | 36.5 | 25.4 | 31.8 | 31 | 35.7 | 31.7 | 36.6 | 32.4 | 31.9 | 38.7 |
| Net profit | 116 | 79.7 | 103 | 102 | 116 | 118 | 110 | 91.7 | 87.7 | 94.8 |
| Net margin | 10.9% | 7.9% | 10.9% | 12.7% | 15.3% | 15.6% | 15.2% | 13.4% | 13.0% | 14.1% |
| EPS (₹) | 4.84 | 3.32 | 4.29 | 4.26 | 4.86 | 4.91 | 4.59 | 3.84 | 3.79 | 4.27 |
| Net profit YoY | −0.2% | −32.2% | −6.2% | +11.3% | +32.7% | +24.1% | – | – | – | – |
Annual results
financial years ending March · from the fourth-quarter filings| ₹ crore | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue from operations | 3,511 | 2,839 | 2,590 |
| Other income | 72 | 107 | 76.3 |
| Total expenses | 3,037 | 2,407 | 2,210 |
| EBITDA | 619 | 534 | 505 |
| EBITDA margin | 17.6% | 18.8% | 19.5% |
| Finance costs | 19.3 | 22 | 49.4 |
| Depreciation | 126 | 80.2 | 76.1 |
| Profit before tax | 525 | 539 | 459 |
| Tax | 124 | 133 | 122 |
| Net profit | 401 | 407 | 337 |
| Net margin | 11.4% | 14.3% | 13.0% |
| EPS (₹) | 16.72 | 17.15 | 15.19 |
| Net profit YoY | −1.4% | +20.8% | – |
EPS is as filed for each period and is not restated for later bonus issues or splits.
Cash flow
annual · ₹ crore| ₹ crore | FY26 | FY25 | FY24 |
|---|---|---|---|
| Operating cash flow | 651 | 442 | 508 |
| Investing cash flow | −512 | −683 | −327 |
| Financing cash flow | −82.6 | 288 | −66.2 |
| Capital expenditure | 44.3 | 30 | 10.7 |
| Free cash flow (CFO − capex) | 607 | 412 | 497 |
Net profit trend
annual, ₹ croreFY24
₹337
FY25
₹407+21%
FY26
₹401−1%
Result filings
as filed with NSE · PDF and XBRL| Period | Basis | Filed | Documents |
|---|---|---|---|
| Q1 FY27 | Consolidated | 30 Jul 2026 | PDF XBRL |
| Q1 FY27 | Standalone | 30 Jul 2026 | PDF XBRL |
| Q4 FY26 | Consolidated | 29 Apr 2026 | PDF on NSE XBRL |
| Q4 FY26 | Standalone | 29 Apr 2026 | PDF on NSE XBRL |
| Q3 FY26 | Consolidated | 29 Jan 2026 | PDF on NSE XBRL |
| Q3 FY26 | Standalone | 29 Jan 2026 | PDF on NSE XBRL |
| Q2 FY26 | Consolidated | 30 Oct 2025 | PDF on NSE XBRL |
| Q2 FY26 | Standalone | 30 Oct 2025 | PDF on NSE XBRL |
| Q1 FY26 | Consolidated | 31 Jul 2025 | PDF on NSE XBRL |
| Q1 FY26 | Standalone | 31 Jul 2025 | PDF on NSE XBRL |
Annual reports
NSE archiveKey ratios
P/E (TTM)5Y avg 30.1×36.5×
P/B5Y avg 5.10×4.67×
ROEFY26, on average equity13.9%
Net margin11.4%
Debt / equity0.00×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹16.67
Market cap₹14,645 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
4.67×
vs 4-point avg 5.10× (−9%)
3.33× low5.10× avg7.06× high
History points are balance-sheet dates (2024 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹4,620 Cr+39%
Net worth₹3,139 Cr+20%
Total borrowings₹0 Cr
Cash & bank balances₹301 Cr+25%
Investments₹1,100 Cr−15%
Inventories₹0 Cr
Trade receivables₹982 Cr+31%
Trade payables₹181 Cr+93%
Change vs the same date a year earlier.
Revenue mix FY26
Enterprise Commercial Solutions70.1%result ₹449 Cr
Enterprise Medical Solutions26.5%result ₹244 Cr
Others3.4%result ₹−32.7 Cr
Segment revenue as reported, before inter-segment eliminations.